{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T04:24:25Z","timestamp":1748233465430,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction and hypothesis<\/jats:title>\n                <jats:p>The aim of this study was to evaluate whether high surgical volume at a single center was associated with lower healthcare costs compared to lower surgical volume in a multicenter setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All patients had symptomatic and anatomical apical prolapse (POP-Q\u2009\u2265\u2009stage II) with or without cystocele and were operated on by a standard surgical procedure using the Uphold mesh. Data on time of resource use in terms of surgery time, hospital stay and re-interventions across 5\u00a0years were compared between the single center (97 patients) and multicenter (173 patients, at 24 clinics). Unit costs for surgical time, inpatient and outpatient visits were extracted from the single-center hospital\u2019s operation analysis program and prime production cost. Total costs were estimated for primary surgery and during 5-year follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Costs for primary surgery were comparable between the single and the multicenter ($13,561\u2009\u00b1\u20092688 and $13,867\u2009\u00b1\u20091177, <jats:italic>P<\/jats:italic>\u2009=\u20090.29). Follow-up costs 5\u00a0years after primary surgery were 2.8 times higher at the multicenter than single center ($3262 vs. $1149, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Mean cost per patient over 5\u00a0years was significantly lower at the single than multicenter [$14,710 (CI: 14,168\u201315,252) vs. $17,128 (CI: 16,952\u201317,305), <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001)].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Using a mesh kit for apical pelvic organ prolapse in a high surgical volume center was associated with reduced healthcare costs compared with a lower volume multiple-site setting. The cost reduction at the high surgical volume center increased over time because of lower surgical and medical re-intervention rates for postoperative complications and recurrence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00192-021-04698-x","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T13:03:34Z","timestamp":1614344614000},"page":"3007-3015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between surgical volumes and real-world healthcare cost when using a mesh capturing device for pelvic organ prolapse: A 5-years comparison between single- versus multicenter use"],"prefix":"10.1007","volume":"32","author":[{"given":"Edward","family":"Morcos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Falconer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie Toresson","family":"Grip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk","family":"Geale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Hellgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Poutakidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Altman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"issue":"3","key":"4698_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/SPV.0000000000000530","volume":"25","author":"P Rahkola-Soisalo","year":"2019","unstructured":"Rahkola-Soisalo P, Mikkola TS, Altman D, Falconer C, Nordic TVM Group. Pelvic organ prolapse repair using the uphold vaginal support system: 5-year follow-up. Female Pelvic Med Reconstr Surg. 2019;25(3):200\u20135.","journal-title":"Female Pelvic Med Reconstr Surg."},{"issue":"4","key":"4698_CR2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00192-019-04106-5","volume":"31","author":"M Gillor","year":"2020","unstructured":"Gillor M, Langer S, Dietz HP. A long-term comparative study of uphold\u2122 transvaginal mesh kit against anterior colporrhaphy. Int Urogynecol J. 2020;31(4):793\u20137.","journal-title":"Int Urogynecol J"},{"key":"4698_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05764-3","author":"C Falconer","year":"2020","unstructured":"Falconer C, Altman D, Poutakidis G, Rahkola-Soisalo P, MikkolaT Morcos E. Long-term outcomes of pelvic organ prolapse repair using a mesh-capturing device when comparing single- versus multicenter use. Arch GynecolObstet. 2020. https:\/\/doi.org\/10.1007\/s00404-020-05764-3.","journal-title":"Arch GynecolObstet"},{"issue":"7","key":"4698_CR4","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jmig.2018.12.007","volume":"26","author":"ST Jeffery","year":"2019","unstructured":"Jeffery ST, Kortz BS, Muavha D, Stolwijk NN, Ras L, Roovers JWR. Morbidity of a single incision transvaginal mesh to correct apical prolapse. J Minim Invasive Gynecol. 2019;26(7):1282\u20137.","journal-title":"J Minim Invasive Gynecol"},{"issue":"8","key":"4698_CR5","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/nau.24125","volume":"38","author":"L Allegre","year":"2019","unstructured":"Allegre L, Debodinance P, Demattei C, Fabbro Peray P, Cayrac M, Fritel X, Courtieu C, Fatton B, de Tayrac R. Clinical evaluation of the uphold LITE mesh for the surgical treatment of anterior and apical prolapse: a prospective, multicentre trial. Neurourol Urodyn. 2019;38(8):2242\u20139.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"4698_CR6","first-page":"91","volume":"29","author":"E Morcos","year":"2018","unstructured":"Morcos E, Altman D, Hunde D, Falconer C, Nordic TVM group. Comparison of single- versus multicenter outcomes for pelvic organ prolapse repair using a mesh-capturing device. IntUrogynecol J. 2018;29(1):91\u20137.","journal-title":"IntUrogynecol J."},{"issue":"2","key":"4698_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejogrb.2012.09.004","volume":"165","author":"R de Tayrac","year":"2012","unstructured":"de Tayrac R, Faillie JL, Gaillet S, Boileau L, Triopon G, Letouzey V. Analysis of the learning curve of bilateral anterior sacrospinous ligament suspension associated with anterior mesh repair. Eur J Obstet Gynecol Reprod Bio. 2012;165(2):361\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Bio"},{"issue":"11","key":"4698_CR8","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00192-013-2177-9","volume":"24","author":"R de Tayrac","year":"2013","unstructured":"de Tayrac R, Sentilhes L. Complications of pelvic organ prolapse surgery and methods of prevention. Int Urogynecol J. 2013;24(11):1859\u201372.","journal-title":"Int Urogynecol J"},{"key":"4698_CR9","unstructured":"Xu K, Soucat A, Kutzin J, et al. Public spending on health: a closer look at global trends. Geneva: World Health Organization; 2018 (WHO\/HIS\/HGF\/HFWorkingPaper\/18.3). Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"6","key":"4698_CR10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s40258-016-0260-3","volume":"14","author":"JP Goldstein","year":"2016","unstructured":"Goldstein JP, Babikian GM, Rana AJ, Mackenzie JA, Millar A. The cost and outcome effectiveness of total hip replacement: technique choice and volume-output effects matter. Appl Health Econ Health Policy. 2016;14(6):703\u201318.","journal-title":"Appl Health Econ Health Policy"},{"issue":"5","key":"4698_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/SLA.0000000000002965","volume":"268","author":"R Vonlanthen","year":"2018","unstructured":"Vonlanthen R, Lodge P, Barkun JS, Farges O, Rogiers X, Soreide K, Kehlet H, Reynolds JV, K\u00e4ser SA, Naredi P, Borel-Rinkes I, Biondo S, Pinto-Marques H, Gnant M, Nafteux P, Ryska M, Bechstein WO, Martel G, Dimick JB, Krawczyk M, Ol\u00e1h A, Pinna AD, Popescu I, Puolakkainen PA, Sotiropoulos GC, Tukiainen EJ, Petrowsky H, Clavien PA. Toward a consensus on centralization in surgery. Ann Surg. 2018;268(5):712\u201324.","journal-title":"Ann Surg"},{"issue":"1","key":"4698_CR12","first-page":"7102","volume":"21","author":"MA Gorin","year":"2014","unstructured":"Gorin MA, Kates M, Mullins JK, Pierorazio PM, Matlaga BR, Schoenberg MP, Bivalacqua TJ. Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission database. Can J Urol. 2014;21(1):7102\u20137.","journal-title":"Can J Urol"},{"key":"4698_CR13","doi-asserted-by":"publisher","first-page":"e791","DOI":"10.1016\/j.wneu.2019.06.034","volume":"129","author":"JS Yoon","year":"2019","unstructured":"Yoon JS, Tang OY, Lawton MT. Volume-cost relationship in neurosurgery: analysis of 12,129,029 admissions from the national inpatient sample. World Neurosurg. 2019;129:e791\u2013802. https:\/\/doi.org\/10.1016\/j.wneu.2019.06.034.","journal-title":"World Neurosurg"},{"issue":"9","key":"4698_CR14","first-page":"1337","volume":"27","author":"D Altman","year":"2016","unstructured":"Altman D, Mikkola TS, Bek KM, Rahkola-Soisalo P, Gunnarsson J, Engh ME, Falconer C, Nordic TVM group. Pelvic organ prolapse repair using the uphold\u2122 vaginal support system: a 1-year multicenter study. IntUrogynecol J. 2016;27(9):1337\u201345.","journal-title":"IntUrogynecol J"},{"issue":"1","key":"4698_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0002-9378(96)70243-0","volume":"175","author":"RC Bump","year":"1996","unstructured":"Bump RC, Mattiasson A, B\u00f8 K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"4698_CR16","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00192-017-3324-5","volume":"28","author":"LL Lua","year":"2017","unstructured":"Lua LL, Vicente ED, Pathak P, Lybbert D, Dandolu V. Comparative analysis of overall cost and rate of healthcare utilization among apical prolapse procedures. Int Urogynecol J. 2017;28(10):1481\u20138.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"4698_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2008.12.008","volume":"113","author":"JP Greving","year":"2009","unstructured":"Greving JP, Vernooij F, Heintz AP, van der Graaf Y, Buskens E. Is centralization of ovarian cancer care warranted? A cost-effectiveness analysis Gynecol Oncol. 2009;113(1):68\u201374.","journal-title":"A cost-effectiveness analysis Gynecol Oncol"},{"issue":"8","key":"4698_CR18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00192-018-3587-5","volume":"29","author":"D Altman","year":"2018","unstructured":"Altman D, Geale K, Falconer C, Morcos E. A generic health-related quality of life instrument for assessing pelvic organ prolapse surgery: correlation with condition-specific outcome measures. Int Urogynecol J. 2018;29(8):1093\u20139.","journal-title":"Int Urogynecol J"},{"issue":"6","key":"4698_CR19","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3109\/0284186X.2012.760848","volume":"52","author":"S Torvinen","year":"2013","unstructured":"Torvinen S, F\u00e4rkkil\u00e4 N, Sintonen H, Saarto T, Roine RP, Taari K. Health-related quality of life in prostate cancer. Acta Oncol. 2013;52(6):1094\u2013101.","journal-title":"Acta Oncol"},{"issue":"1","key":"4698_CR20","doi-asserted-by":"publisher","first-page":"38.e1","DOI":"10.1016\/j.ajog.2016.08.035","volume":"216","author":"RE Gutman","year":"2017","unstructured":"Gutman RE, Rardin CR, Sokol ER, Matthews C, Park AJ, Iglesia CB, Geoffrion R, Sokol AI, Karram M, Cundiff GW, Blomquist JL, Barber MD. Vaginal and laparoscopic mesh hysteropexy for uterovaginal prolapse: a parallel cohort study. Am J Obstet Gynecol. 2017;216(1):38.e1-38.e11. https:\/\/doi.org\/10.1016\/j.ajog.2016.08.035.","journal-title":"Am J Obstet Gynecol."},{"issue":"10","key":"4698_CR21","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s00192-020-04407-0","volume":"31","author":"N Ng-Stollmann","year":"2020","unstructured":"Ng-Stollmann N, F\u00fcnfgeld C, Gabriel B, Niesel A. The international discussion and the new regulations concerning transvaginal mesh implants in pelvic organ prolapse surgery. Int Urogynecol J. 2020;31(10):1997\u20132002.","journal-title":"Int Urogynecol J"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-021-04698-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-021-04698-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-021-04698-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T15:23:59Z","timestamp":1634916239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-021-04698-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["4698"],"URL":"https:\/\/doi.org\/10.1007\/s00192-021-04698-x","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"type":"print","value":"0937-3462"},{"type":"electronic","value":"1433-3023"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicst of interest"}},{"value":"Edward Morcos: None.Christian Falconer has received speaking and advisory honoraria from Boston Scientific and Johnson & Johnson.Emilie Toresson Grip is an employee of Quantify Research AB.Kirk Geale is an employee, board member and options holder of Quantify Research AB.Katarina Hellgren: None.Georgios Poutakidis: None.Daniel Altman has received speaking and advisory honoraria from Gedeon Richter, Pfizer, Astellas, Invent Medic and Gynecare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure"}},{"value":"The studies were approved by The Stockholm Regional Board of Ethics at the Karolinska Institutet, Stockholm, Sweden, and ethic review committees in the respective countries and were registered at ; the single-center study NCT03077490 and the multicenter study NCT01823055.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}